"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 1 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 2 | 4 |
| 2002 | 1 | 2 | 3 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 3 | 5 |
| 2006 | 6 | 3 | 9 |
| 2007 | 1 | 3 | 4 |
| 2008 | 4 | 5 | 9 |
| 2009 | 3 | 2 | 5 |
| 2010 | 8 | 4 | 12 |
| 2011 | 6 | 6 | 12 |
| 2012 | 6 | 3 | 9 |
| 2013 | 4 | 3 | 7 |
| 2014 | 11 | 10 | 21 |
| 2015 | 12 | 10 | 22 |
| 2016 | 6 | 10 | 16 |
| 2017 | 12 | 8 | 20 |
| 2018 | 15 | 8 | 23 |
| 2019 | 19 | 8 | 27 |
| 2020 | 24 | 1 | 25 |
| 2021 | 15 | 6 | 21 |
| 2022 | 22 | 0 | 22 |
| 2023 | 13 | 0 | 13 |
| 2024 | 11 | 5 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation. Am J Hematol. 2025 Mar; 100(3):383-392.
-
Decreasing chronic graft-versus-host disease rates in all populations. Blood Adv. 2024 Nov 26; 8(22):5829-5837.
-
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv. 2024 10 22; 8(20):5306-5314.
-
Incidence of bacterial blood stream infections in patients with acute GVHD. Bone Marrow Transplant. 2025 Jan; 60(1):52-57.
-
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity. Blood Adv. 2024 10 08; 8(19):5137-5145.
-
Chronic graft-versus-host disease: unresolved complication or ancient history? Blood. 2024 09 26; 144(13):1363-1373.
-
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2024 Sep 19; 391(11):1002-1014.
-
Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant. Transplant Cell Ther. 2024 Dec; 30(12):1193.e1-1193.e8.
-
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients. Blood Adv. 2024 09 10; 8(17):4740-4750.
-
Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation. Blood Adv. 2024 09 10; 8(17):4651-4657.